- BNF:
- 5.3.3
- Status:
- Red
- Decision Date:
- March 2015
Comments
RED: NICE TA 330:Hepatitis C treatment.
Commissioning responsilibilty falls within the remit of NHS England.
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
- 4: Specifically designated as “hospital only” by product licence or by DH/NICE
search again